Fundraising FoxHepaRegeniX
Tuebingen, DE · 5 known investors
Find your way into HepaRegeniX
Sign up to see every warm intro you have to HepaRegeniX
- Paths you didn't know you had: your email and LinkedIn already hold routes to the HepaRegeniX team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
HepaRegeniX is a clinical-stage biotech company developing therapies that treat acute and chronic liver diseases by promoting liver regeneration. Its approach aims to reverse disease progression rather than only manage symptoms.
Investors · 5
How we know: coparion's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: globenewswire.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: globenewswire.com · Not right? Tell us
Also in the syndicate · 1
Funding
SEC filings, press & company announcements- Undisclosed amountSeries CJul 2024
Vesalius Biocapital IV (lead), Boehringer Ingelheim Venture Fund (BIVF), High-Tech Gründerfonds (HTGF), Novo Holdings
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does HepaRegeniX do?
- HepaRegeniX is a clinical-stage biotech company developing therapies that treat acute and chronic liver diseases by promoting liver regeneration. Its approach aims to reverse disease progression rather than only manage symptoms.
- Who are HepaRegeniX's investors?
- HepaRegeniX's investors include coparion, Boehringer Ingelheim Venture Fund, HTGF, Novo Holdings.
- Where is HepaRegeniX headquartered?
- HepaRegeniX is headquartered in Tuebingen, DE.